ArticleJTO clinical and research reports2024

Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC.

Johan F Vansteenkiste et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.